Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic abnormalities in marginal zone B-cell lymphoma.

J Dierlamm1, I Wlodarska, L Michaux

  • 1Department of Oncology and Hematology, University Hospital Eppendorf, Hamburg, Germany.

Hematological Oncology
|May 8, 2000
PubMed
Summary

Marginal zone B-cell lymphomas (MZBCL) may develop due to the disruption of apoptosis. Genetic alterations like t(11;18) and trisomy 3 are implicated in MZBCL pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.

Bone marrow transplantation·2014
Same author

No chromosome arm unturned: in memory of Roland Berger 1934-2012.

Leukemia·2014
Same author

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.

Leukemia·2008
Same author

Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.

Leukemia·2007
Same author

Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL.

Leukemia·2007
Same author

A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.

Leukemia·2007

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Marginal zone B-cell lymphoma (MZBCL) is a distinct subtype of B-non-Hodgkin's lymphoma.
  • Recent advances have elucidated genetic mechanisms in MZBCL pathogenesis and progression.

Purpose of the Study:

  • To explore the genetic underpinnings of MZBCL, focusing on apoptosis regulation and chromosomal abnormalities.
  • To identify key genes and chromosomal regions involved in the development of MZBCL.

Main Methods:

  • Analysis of chromosomal abnormalities, including structural (t(11;18), t(1;14)) and numerical (trisomy 3) changes.
  • Gene analysis focusing on API2, MLT, BCL10, FAS, and BCL6.
  • Comparative genomic hybridization (CGH) to delineate critical chromosomal regions.

Related Experiment Videos

Main Results:

  • The t(11;18) translocation affects API2 and MLT genes, frequent in extranodal MALT lymphoma.
  • BCL10 gene alterations were found in MALT lymphoma with t(1;14).
  • Inactivating FAS gene mutations and trisomy 3 are common in MZBCL, suggesting apoptosis abrogation as a key mechanism.

Conclusions:

  • Abrogation of apoptosis is a central pathogenetic mechanism in MZBCL development.
  • Trisomy 3 is the most frequent numerical chromosomal change in MZBCL, with critical regions identified on 3q.
  • BCL6 proto-oncogene rearrangements in MZBCL suggest its potential role in disease progression.